SCHEMBL8980211

SCHEMBL8980211

C[C@]12CCC(=O)C=C1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)OCC[C@@H]12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 13/20 0.67
SMN1; SMN2 Q16637 5/20 0.43
ALDH1A1 P00352 3/20 0.43
NR1I2 O75469 2/20 0.43
NR3C1 P04150 2/20 0.43
PGR P06401 2/20 0.43
NR3C2 P08235 2/20 0.43
CYP3A4 P08684 2/20 0.43
AR P10275 2/20 0.43
NR1H4 Q96RI1 2/20 0.43
MAPT P10636 2/20 0.43
MAPK1 P28482 2/20 0.43
BLM P54132 2/20 0.43
PMP22 Q01453 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ESR1 P03372 1/20 0.43
TP53 P04637 1/20 0.43
VDR P11473 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8980219 1.00 CYP19A1 (0.67) CYP19A1SMN1; SMN2ALDH1A1NR1I2NR3C1
SCHEMBL8759011 0.81 SHBG (0.66) CYP19A1SMN1; SMN2ALDH1A1NR1I2NR3C1
SCHEMBL8759018 0.81 SHBG (0.66) CYP19A1SMN1; SMN2ALDH1A1NR1I2NR3C1
SCHEMBL42712 0.80 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL42713 0.80 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL2600419 0.80 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL6821320 0.79 CYP19A1 (0.78) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL7097095 0.79 CYP19A1 (0.78) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL8980169 0.79 CYP19A1 (0.68) CYP19A1SMN1; SMN2ALDH1A1NR1I2NR3C1
SCHEMBL8760308 0.79 CYP19A1 (0.72) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5519051-A AROMATASE INHIBITORS USEFUL FOR TREATMENT OF DISEASES CAUSED BY EXCESS OF ESTROGEN, FOR EXAMPLE, BREAST CANCER, UTERINE CANCER TEIKOKU HORMONE MFG. CO., LTD. (JP) 1996-05-21 US disclosed
EP-0582713-A1 NOVEL OXA- OR AZASTEROID DERIVATIVE TEIKOKU HORMONE MFG. CO., LTD. (JP) 1994-02-16 EP disclosed